As the world’s pharmaceutical industry continues its recent spree of mergers and acquisitions, the consolidation seems to continue with AbbVie’s latest attempt to acquire one of its competitors.
The US pharmaceutical firm just raised its offer to purchase UK-based rival Shire to about $51 billion after an earlier offer was rejected. …read more
Source: Global Competition Law Blogs